The male god of magic capital

Chengtian Holdings, the president's office, Luo Cheng is drinking tea leisurely.

"Yes, the stock price did not disappoint me."

This time, the share price of Chengtian Holdings broke through the 3 mark, and its market value reached 300 billion, which attracted many media reports. After all, Chengtian Holdings is the most expensive stock in Big A, and every time the stock price rises and falls, it will cause heated discussions.

This time, the profit was 80 billion, and the commission was 16 billion, which made the investors in the market extremely excited. Those who were not optimistic about Chengtian Holdings before were slapped in the face.

Investors in the market are also questioning whether the share price of Chengtian Holdings will exceed 5 yuan in the future?

Perhaps this year's stock price will triple or quadruple, breaking through 3 yuan per share.

In the eyes of emotional investors, the share price of Chengtian Holdings will only get higher and higher, there is no limit, and it will be a matter of time before it breaks 10 yuan a share.

In the eyes of rational investors, everything has a limit. The stock price of Chengtian Holdings has reached its end, and it is impossible to go higher. To reach a market value of 500 billion, or a market value of 500 billion, it needs continuous high performance, and With the skyrocketing asset scale and the small foundation of Chengtian Holdings, it is extremely difficult for the market value to exceed [-] billion, let alone a market value of [-] billion.

So the two groups commented on the heated dispute below.

"The stock price of Chengtian Holdings will break through 10 yuan sooner or later!"

Immediately, an investor said: "Shabi, do you know what performance and asset scale is required for 10 yuan a share? Is there any place in Chengtian Holdings that can support the 10 yuan share price? What does it rely on? By A rotten subsidiary? There is a limit to the asset size of Chengtian Private Equity Fund and Chengtian Public Fund."

"Hehe, I only look at the man who is the God of Finance in Shanghai, not any subsidiary company!"

"Yes, I have confidence in the God of Finance in Shanghai, and I am optimistic that he can make Chengtian Holdings' future share price break through 10 shares."

"Shabi, hehe, I simply don't believe that the stock price can reach 5 shares, let alone 10 shares."

"Fuckers, do you know what kind of performance is needed to support a share price of 10 yuan?"

"Idiot, as long as the male god of finance in Shanghai is here, I am optimistic about this legendary male god!"

···
Luo Cheng glanced at the comments and smiled.

The share price of Chengtian Holdings has now reached 3 yuan per share. Well, it is indeed very high. It is very difficult to rush to 5 yuan per share. It needs performance support and a huge increase in asset size.

"Next is the Hong Kong stock account and A-share account of the Luo family fund."

At present, there are still 5 million Hong Kong dollars in the Hong Kong stock account of the Luocheng Family Foundation, and 2 million yuan in the A-share account, all of which are idle.

Chengtian Private Equity Fund and Chengtian Public Fund don't need to be managed for the time being, the next step is to operate the account of the family fund.

In the future, after Luo Cheng completes the establishment of the financial group and the Chengtian Department in Shanghai, he will expand to Xiangjiang, and use Xiangjiang as a springboard to go international.

At that time, it was necessary to acquire a large listed group in Xiangjiang, so the Hong Kong stock account of the Luo family fund also needed to earn a lot of money.

Then he opened the trend chart of the Hong Kong stock market, made a good selection, and quickly chose Jinxin Fertility, a company that has been rumored recently that it will cooperate with Shenzhou Baekje Biological Company and will receive a large number of orders from Shenzhou Baekje.

This Shenzhou Baekje company is a giant medical group jointly controlled by Tianhai Group, Nuoan Group, and Jardine Group. Its market value exceeded 4000 billion Hong Kong dollars before, but the stock price was too high, and then it was shorted by Luo Cheng, which led to the selling rhythm. Now The market value is still 3200 billion. Although Luo Cheng hindered the financing of Shenzhou Baekje, Wu Tianhai and others still allowed it to raise funds, but the amount of financing was much less.

And this Jinxin Fertility seems to be washing the market now, the stock price is at 14 Hong Kong dollars per share, and the market value is 350 billion. Luo Cheng is not in a hurry to buy.

"If this Jinxin Fertility becomes a major supplier of Shenzhou Baekje, the stock price will definitely skyrocket very high in the future, and with Wu Tianhai and others' pessimism, they will definitely smash the stock price to a low level and eat enough to buy it." Plate, pull it up again."

Luo Cheng planned to enter the arena and have a good time with Wu Tianhai's financial power.

As for the A-shares, Luo Cheng has not yet decided which stock the Luo Family Fund's A-share account will operate. It should be a stock in the medical sector. After all, there are many stocks in the medical sector, and they are also very popular, suitable for short-term speculation.

Chengtian Manor is currently under construction. In the mid-term, Luo Cheng will have to pay 6 million for the project. Currently, there is still 2 million in the A-share account. Luo Cheng has to find a way to double it as soon as possible.

And the 2 million capital is difficult to double in the stocks of listed companies with a very high market value, so it is still necessary to have a small company with a market value of less than [-] billion.

"Which stock should I choose?"

Luo Cheng looked at those medical companies with a market value of less than [-] billion and fell into deep thought.

Thinking of what Gao Yang told him before, Gao Yu from Taixin Mixed Fund, Qin Qihai, Xu Rendong and others from Hangzhou planned to operate the stocks of Qixing Eye Medicine Company!
Immediately, Luo Cheng opened the stock of Qi Xing's eye medicine, and was stunned.

Its stock price soared today, from 13.00 yuan per share to 16.90 yuan per share, an increase of 30%, which directly hit the daily limit.

Luo Cheng was a little surprised.

Since its listing, the stock of Qixing Eye Medicine has reached as high as 57 yuan per share, and then has been falling. Two years later, the lowest fell to 12.48 yuan.

Then it started to rise last Friday, rushing to 13 yuan, and this Monday's daily limit, rushing to the 16.90 position.

"Pull first, let the retail investors who have been trapped recently sell their stocks?"

Before Gao Yang said that Gao Yu of Taixin Mixed Fund, Qin Qihai, Xu Rendong and others from Hangzhou planned to operate the stock of Qixing Eye Medicine Company, Luo Cheng was half-believing at that time, but now it seems that this is true.

Moreover, this Xingqi eye drug company is competing with a partner of Aier Ophthalmology called Shengnuo Biological.

Senna Biological Company was supported by Bosera Fund Management Company, and the major shareholder is Bosera Securities.

Xingqi Ophthalmology Company is a small company that has raised many times, and the founder’s shareholding has been almost diluted. The key point is that this company has a key product that Aier Ophthalmology Company needs, and it can compete with Shengnuo Biologics .

This time, Bosera Fund Management Company bought 280 billion worth of shares from Luo Cheng, and has become the major shareholder of Aier Ophthalmology, with a shareholding ratio as high as 12.8%, but it does not control the absolute right to speak.

The original order that belonged to Shengnuo Biotech may be taken away by Xingqi Eye Medicine Company.

The two sides are going to fight, probably starting from a small company!
The stock price of Xingqi Eye Drug Company has already begun to wash up, and the stock price of Shengnuo Biologics fell today, which is obviously short-selling.

It must be Qin Qihai, Gao Yu, Xu Rendong and others who are manipulating the stock of Xingqi Eye Medicine.

Luo Cheng immediately decided to make a big mouse warehouse.

To be honest, Luo Cheng is not optimistic about Shengnuo Biotech either. This Xingqi eye medicine is really better than Shengnuo Biotech's.

At present, the market value of Xingqi eye medicine is underestimated, while the market value of Shengnuo Bio is overestimated, so it is normal to be shorted.

And if Xingqi Eye Drug Company takes away the order from Shengnuo Biologics, the stock price will rise even more violently.

"If you engage in a mouse warehouse, the stock price of Xingqi Eye Medicine will definitely be suppressed tomorrow, and retail investors will be asked to sell their stocks. I'll just eat at high positions!"

Luo Cheng sneered.

The next day, August 4th, Tuesday.

As the stock market opened, the stock price of Xingqi Eye Medicine turned around and plummeted, all the way down to 16.00!

Luo Cheng started to buy, supported the stock price, and steadily pulled it up!
···
Hangzhou, New Century Grand Hotel, Qin Qihai, Xu Rendong, and Gao Yu were a little surprised.

The three of them had a great time last weekend, and they have been operating the stock of Xingqi Eye Medicine for the past two days.

"There are funds to enter the market to buy!"

"It should be chasing up. It's okay. We will continue to sell to trap these retail investors and let them cut their meat at a lower position."

"I think so too, trap these retail investors!"

Gao Yu began to sell.

And Luo Cheng kept buying, and the stock price of Xingqi Eye Medicine rose all the way

17.11
18.55
19.77
20 yuan per share!
A new high has been set!

Gao Yu, Qin Qihai, Xu Rendong and others were dumbfounded.

"This is not retail investors, it's hot money!"

"Hot money has entered the market!"

"Hehe, that's just right, kill him!" Soon Gao Yu dropped the stock price back to 16 yuan per share!
"Trap him to death!"

"The hot money doesn't have much money, so daring to enter the market to chase high is simply courting death!"

But it was pulled back again, and it returned to 20 yuan per share again!
Gao Yu, Qin Qihai, and Xu Rendong were dumbfounded again!

"This, this, this?" Qin Qihai: "Xiao Gao, keep smashing!"

Xu Rendong: "I think it's better to wait and see what this hot money wants to do!"

Gao Yu: "It must be a mouse warehouse, let the hot money be pulled first, and we won't wash the dishes for now!"

And Luo Cheng didn't get promoted anymore!

In the end, the stock price of Xingqi Eye Medicine closed at 20 yuan per share!

Gao Yu and others also knew that the biggest buyer was Citigroup's Mordu Garden Shiqiao Road Securities Sales Department, with a purchase amount of 1 million.

A special seat for the God of Finance in Shanghai!
You bastard, it's this guy!

This guy is engaged in a mouse warehouse!

"So it's this guy!" Gao Yu sneered, "That guy Gao Yang must have told him!"

Qin Qihai: "Then what should we do?"

Xu Rendong: "Let him play by himself, we won't wash the dishes for now!"

Gao Yu chuckled: "Screw him to death!"

The following day, June 4th, Wednesday.

The stock market opened, and Luo Cheng continued to rise.

20.44
21.88
22.41
23.44
24.00
It skyrocketed by 20%, and Luo Cheng stopped raising, and the stock price turned around and fell shortly after. When it fell back to the 20.00 position again, Luo Cheng made a huge profit again, causing the stock price to rush to the 24.00 position again.

"It's done, the mouse warehouse has been held!" Luo Cheng bought a total of 2 million shares in the past two days, with an average price of 20.00 and 1000 million shares.

Luo Cheng also knew that Gao Yu, Xu Rendong, Qin Qihai and others must have discovered it, but he didn't care, so he set up a mouse warehouse and held it for a long time.

And when the market opened in the afternoon, Gao Yu smashed the stock price again, falling to 20.00, and then stopped smashing, trying to lure Luo Cheng to continue entering the market. Unfortunately, the A-share account of the Luo Family Foundation ran out of funds, otherwise Luo Cheng Keep going, let Gao Yu and Qin Qihai look good.

And Gao Yu, Qin Qihai, Xu Rendong and others saw that the financial god of the devil city did not raise the stock any more, obviously they had finished building their positions.

Gao Yu: "From now on, we will wash the dishes at a low level, just ignore this rat warehouse."

Qin Qihai: "Then what should we do after Xingqi Eye Medicine wins a huge order from Aier Ophthalmology? Could it be that the financial god of the devil is lying down and making money?"

Xu Rendong: "It's not in a hurry now. There is still a long time to go. Bosera Fund Management is behind this Shengnuo Biotech. It holds 12.8% of the shares of Aier Ophthalmology. Now it has a lot of power in the board of directors."

Gao Yu didn't say anything more.